Vaccine

Article	Citations
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	281
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	173
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	130
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	123
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	102
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	99
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	99
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	87
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	86
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	86
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	80
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	77
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	72
The social lives of the SARS-CoV-2 vaccines: A qualitative study of vaccine understandings and decision-making among people of Black ethnicities in London, UK	69
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	65
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	62
Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus	62
Nationwide rollout of HPV vaccination in Nepal: Early key insights	61
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	59
Editorial Board/Aims and Scope	58
Editorial Board/Aims and Scope	57
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	56
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	55
The Brucella abortus A19ΔfeuPΔfeuQ double-mutant is highly attenuated and confers protection in BALB/c mice	54
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	52

Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	49
Advancing the use of vaccine impact modeling for immunization decisions in low- and middle-income countries	48
Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent	47
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	45
Racial and ethnic differences among Mpox vaccination recipients by vaccination facility type in New York City—August–December 2022	44
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	44
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	42
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	42
Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides	41
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	41
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	40
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	40
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	40
Corrigendum to “I want to chat with a person”: a qualitative longitudinal cohort study in England exploring drivers of sub-optimal childhood vaccination uptake” [Vaccine 62 (2025) 127462]	40
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	40
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge” [Vaccine 61 (2025) 127347]	40
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	39
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	39
Pneumococcal vaccines: A dose of change. Vaccine failures and breakthrough infections in Belgian children during the PCV13 era (2019–2024)	38
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	38
COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil	38
A scoping review of multicomponent interventions to improve uptake of routine childhood vaccines in low- and middle-income countries	38
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	38
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	37
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	37
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic	37
IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route	37
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	37
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	37
Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adults	37
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	36
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	36
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort	36
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	36
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	35
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	35
A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge	34
Corrigendum to “A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme” [Vaccine 42(20) (2024) 125988	34
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	34
Determinants of immunization in polio super high-risk union councils of Pakistan	34
Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness—IVY network, January 24, 2022–September 1, 2024	34
The U.S. COVID-19 vaccination program: A look back and future directions	33
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	33
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	33
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	32
Analysis of HPV vaccination and influencing factors among 9–14-year-old girls in underdeveloped areas of northwestern China: A cross-sectional survey report on guardians	32
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	32
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England	32
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	32
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	31

Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	30
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	30
Immunogenicity and safety of Sabin-strain inactivated poliovirus vaccine in infants: a systematic review and meta-analysis	30
Collateral damage from debunking mRNA vaccine misinformation	30
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	30
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	30
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination	30
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	29
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	29
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	29
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	28
Dropout from the pentavalent vaccine series among children aged 12–23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers	28
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	28
Consultation report - gonococcal immunoassays and standards for vaccine development	28
Immunogenicity of 2 versus 3 dose HPV vaccination by HIV infection status in Eswatini	28
BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy	27
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	27
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	27
Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study	27
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	27
Vaccine misinformation among Arabic-speakers in Australia and the audience and appetite for a game-based intervention	27
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	27
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	27
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	26
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	26
Systematic review of pro-equity strategies to improve vaccination among priority populations	26
Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models	26
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	26
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	26
A modified self-controlled case series on mortality risk following primary series doses of COVID-19 vaccines in U.S. Medicare beneficiaries aged 65 years and older	26
Effectiveness of the varicella vaccine in the real world, a matched case-control study	26
Weaving a public health network: Process and results from an evaluation of CDC’s Prevention Research Centers Vaccine Confidence Network	26
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women	26
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	26
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	26
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	25
Characteristics of reported mumps cases in the United States: 2018–2023	25
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	25
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series	25
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages	25
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	25
Measles seroprevalence among individuals serologically tested in Ontario, Canada	25
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	25
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	25
State minor consent laws and human papilloma virus vaccine uptake: An analysis of the 2023 National Immunization Survey-Teen Data	25
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	25
Editorial Board	24
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	24
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	24
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	24
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs	24
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study	24
Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo	24
COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan	24
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization R	23
Vaccine value profile for Salmonella enterica serovar Paratyphi A	23
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	23
Analyzing attitudes toward COVID-19 vaccine decision making among pregnant women in Pakistan	23
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization	23
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	23
New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada	23
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged	23
Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China	23
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	23
Genetic and molecular basis for low efficacy of vaccine strains against canine distemper virus in Brazil	23
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	23
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	22
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	22
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission	22
A point-mutated Ag85B antigen improves recombinant bacterial expression and protects mice from aerosol M. tuberculosis challenge	22
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	22
Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine	22
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	22
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh	22
Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria	22
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students	22
Using latent class analysis of survey data to explore parent behaviors and attitudes regarding children's COVID vaccinations	22
Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model	22
Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models	21
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6–23 months in Kenya: 2019–2021	21

Editorial Board	21
Editorial Board/Aims and Scope	21
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	21
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)	21
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B.1.1.529 (Omicron) variant	21
The relationship between state vaccination exemption policies and MMR vaccination trends in the U.S.	21
Editorial Board/Aims and Scope	21
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	21
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	21
Safe and efficacious inactivated immersion vaccine against KG+ phenotype of emerging bacterial pathogen Lactococcus garvieae for early developmental stage of rainbow trout (Oncorhynchus mykiss) in Ind	21
Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: A mixed methods study	21
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	21
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	21
Crowdfunding narratives and the valuation of vaccines for COVID-19	21
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	21
Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season	20
COVID-19 hoax belief endorsement and its implications for vaccine uptake: Investigating the role of perceived threat	20
Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data	20
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	20
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	20
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	20
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observat	20
Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves	20
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan	20
The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences	20
Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children	20
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates	20
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	20
Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents	20
Enhancing NA immunogenicity through novel VLP designs.	20
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer	20
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study	19
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	19
ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation	19
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study	19
Accuracy of self-reported vaccination status using surveys in safety-net, integrated and rural health systems in Colorado	19
Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment	19
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	19
High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV	19
Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib)	19
Erratum to “Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with down syndrome” [Vaccine 73 (2026) 128079]	19
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	19
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023	19
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	19
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	19
Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Côte d’Ivoire	19
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	19
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens	19
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	18
Factors associated with vaccination intention and uptake over time in a sample of older Australians	18
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	18
Post-vaccination fever in infants: Real-world data analysis using a childcare mobile application	18
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	18
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	18
COVID-19 vaccine decision-making among Black women: A qualitative study	18
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	18
Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1	18
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	18
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurell	18
Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children	18
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	18
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	18
An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis	18
Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities	18
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III	18
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	18
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	18
From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis	17
Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster	17
Mucosal COVID-19 vaccines in clinical development	17
Editorial Board	17
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets	17
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	17
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	17
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	17
Corrigendum to “Breastfeeding women’s attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research” [Vaccine 41 (2023) 1198–1208]	17
Drivers of decision-making for future adult vaccines: a best–worst scaling among community members and health care workers in Zambia	17
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection	17
HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review	17
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	17
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia	17
The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review	17
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	17
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	17
Corrigendum to “A significant decrease in anogenital warts incidence following the implementation of a national human papillomavirus immunization program in Israel” [Vaccine 80 (2029) 128516]	17
County-level correlates of completed HPV vaccination in Indiana	17
Seroprotection against tetanus in the Italian general population	17
Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverage	17
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	17
Addressing vaccine misinformation: The critical need for complete product information disclosure	16
Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus	16
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis	16
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age	16
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis	16
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients	16